ETENDERS

Contract award notice

Information

Published

Date of dispatch of this notice: 26/09/2018

External Reference: 2018-240822

TED Reference: 2018/S 186-420045

Contract award notice

Contract award notice

Results of the procurement procedure

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Our Lady's Children's Hospital, Crumlin
N/A
Dublin 12
Dublin
Ireland
IE
Contact person: robert keogh
Telephone: +353 014096598
E-mail: robert.keogh@olhsc.ie
Internet address(es):
Main address: http://www.olchc.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/384

I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Supply of Infliximab or biosimilar
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.1.6)

Information about lots

This contract is divided into lots: no
II.1.7)

Total value of the procurement

Value excluding VAT:  550000.00  EUR
II.2)

Description

II.2.2)

Additional CPV code(s)

33600000  -  Pharmaceutical products
II.2.3)

Place of performance

Main site or place of performance:  
Our Lady's Children's Hospital, Crumlin
II.2.4)

Description of the procurement

To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
II.2.5)

Award criteria

Criteria below
Quality criterion  -  Name:  Quality of Supply  /  Weighting:  20%
Quality criterion  -  Name:  Quality and Fitness for Purpose  /  Weighting:  20%
Quality criterion  -  Name:  Value Add  /  Weighting:  15%
Cost criterion  -  Name:  Overall Cost  /  Weighting:  45%
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.1)

Previous publication concerning this procedure

Notice number in the OJ S: 2018/S 079-176043

Section V: Award of contract

Contract No: RFT 131644

Title: RFT 131644 - Supply of Infliximab or biosimilar

A contract/lot is awarded: yes
V.2)

Award of contract

V.2.1)

Date of conclusion of the contract

17/08/2018
V.2.2)

Information about tenders

Number of tenders received:  3
Number of tenders received from SMEs:  0
Number of tenders received from tenderers from other EU Member States:  0
Number of tenders received from tenderers from non-EU Member States:  0
Number of tenders received by electronic means:  0
The contract has been awarded to a group of economic operators :  no
V.2.3)

Name and address of the contractor

Pfizer Healthcare Ireland
9 Riverwalk, National Digital Park
Dublin
22
IE
Telephone: +44 353526186000
E-mail: caroline.reidy@pfizer.com
Fax: +44 353526136311

The contractor is an SME : no
V.2.4)

Information on value of the contract/lot (excluding VAT)

Lowest offer:  512448.00  EUR / Highest offer:  559000.00  EUR   taken into consideration

Section VI: Complementary information

VI.4)

Procedures for review

VI.4.1)

Review body

High Court
Inns Quay
Dublin
7
IE